A Psychomotor Group Intervention for Young Adults With Anxiety Symptoms

June 25, 2026 updated by: VIA University College

Development and Feasibility of a Group-based Psychomotor Intervention for Anxiety in Young Adults

The goal of this clinical trial is to learn if a psychomotor (a body-oriented therapy) group intervention can be feasibly delivered to a group of young adults (age 18-35) with anxiety symptoms within a higher educational setting.

The main questions it aims to answer are:

  • Is it possible to recruit and retain participants in this intervention?
  • Is the intervention acceptable and tolerable to participants?
  • Do participants complete the planned sessions and assessments?

Participants will:

  • Attend one weekly group session over ten consecutive weeks
  • Participate in active and contemplative body-based exercises
  • Complete questionnaires about their mental health and interviews about their experiences of participating

Study Overview

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Region Midt
      • Aarhus, Region Midt, Denmark, 8200
        • VIA University College

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age between 18 and 34 years
  • A score of at least 2 on item 10 of the Anxiety Symptom Scale (indicating the perceived strain of the experienced anxiety symptoms) and at least 1 on one or more of items 1-3 (generalized anxiety symptoms and avoidance behavior)
  • Sufficient Danish language proficiency to participate in group sessions and interviews

Exclusion Criteria:

  • Physical or psychological conditions that prevents participation in group-based or bodily-activities, such as significant musculoskelatal impairment or current, untreated episodes of psychosis
  • Ongoing alcohol or substance abuse
  • Concurrent participation in another body-oriented intervention program

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Psychomotor intervention group
Ten weekly sessions of a psychomotor therapy group program. Session duration: 2½ hours. Group size: 12 participants. Sessions include psychoeducational content and body-oriented exercises such as breathing exercises, relaxation exercises, body scans, or grounding exercises.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants recruited
Time Frame: For each participant: 20 minutes during the three month enrollment period.
Enrollment during a three month period from June 2025 to September 2025. Enrollment interview was approximately 20 minutes. Participants had the option of attending a one hour information meeting.
For each participant: 20 minutes during the three month enrollment period.
Number of participants retained
Time Frame: From enrollment to end of intervention at 11 weeks
From enrollment to end of intervention at 11 weeks
Attendance
Time Frame: From beginning of intervention to end of intervention at 11 weeks
Number of participants attending each of the ten weekly sessions
From beginning of intervention to end of intervention at 11 weeks
Acceptability to participants
Time Frame: Post intervention at 12 weeks
Evaluated through qualitative interviews with a duration of 45-60 minutes
Post intervention at 12 weeks
Fidelity of the intervention
Time Frame: From beginning of intervention to end of intervention at 11 weeks
The extent to which intervention components were administered as intended. This was registered by an observer who registered any deviations from a therapy manual.
From beginning of intervention to end of intervention at 11 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Beck Anxiety Inventory
Time Frame: Baseline and post-intervention at 11 weeks
21 items rated on a four-point Likert scale with scores ranging rom 0 (no anxiety) to 21 (worst possible anxiety)
Baseline and post-intervention at 11 weeks
Changes in Perceived Stress Scale
Time Frame: Baseline and post-intervention at 11 weeks
Ten items rated on a five-point Likert scale with scores ranging from 0 (no stress) - 40 (maximum stress)
Baseline and post-intervention at 11 weeks
Changes i WHO-Five Well-Being Index
Time Frame: Baseline and post-intervention at 11 weeks
A five-item measure rated on a six-point Likert scale with scores ranging from 0 (worst possible well-being) to 100 (maximum well-being)
Baseline and post-intervention at 11 weeks
Changes in Multiple Assessment of Interoceptive Awareness
Time Frame: Baseline and post-intervention at 11 weeks
Body awareness measured through 32 items across eight subscales rated on a six-point Likert scale, reported as mean scores on each subscale (range 0-5)
Baseline and post-intervention at 11 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 12, 2025

Primary Completion (Actual)

December 18, 2025

Study Completion (Actual)

December 18, 2025

Study Registration Dates

First Submitted

June 12, 2026

First Submitted That Met QC Criteria

June 25, 2026

First Posted (Actual)

July 2, 2026

Study Record Updates

Last Update Posted (Actual)

July 2, 2026

Last Update Submitted That Met QC Criteria

June 25, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Small scale feasibility study data.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety

Clinical Trials on Ten weekly psychomotor therapy group sessions

3
Subscribe